Literature DB >> 8586494

Pars planitis: epidemiology and clinical outcome in a large community hospital in Mexico City.

G Ortega-Larrocea1, L Arellanes-Garcia.   

Abstract

Medical records of 51 patients with a diagnosis of pars planitis (97 eyes) were reviewed. Based upon the severity of vitreous inflammation, in 34 eyes (35%) the condition was classified as mild, in 38 (39%) as moderate, and in 25 eyes (26%) as severe. Vascular sheathing was present in 51 eyes (53%), snowballs in 42 (43%), snowbanks in 29 (30%), cataract in 19 (20%), cystoid macular edema in 26 (27%), retinal detachment in 4 (4%) and glaucoma in 3 (3%) eyes. Treatment consisted of prednisone and periocular injections of deposteroids or immunosuppressive agents; 13 patients required surgery for retinal repair, glaucoma, vitreous opacities or cataract. After treatment the visual acuity improved in 58% of the eyes, did not change in 33%, and worsened in 9%.

Entities:  

Mesh:

Year:  1995        PMID: 8586494     DOI: 10.1007/bf00133182

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  21 in total

Review 1.  Intermediate uveitis: epidemiology, age and sex distribution.

Authors:  C Althaus; R Sundmacher
Journal:  Dev Ophthalmol       Date:  1992

2.  Fluorescein angiography in intermediate uveitis.

Authors:  F Schmidt
Journal:  Dev Ophthalmol       Date:  1992

3.  Ciclosporin (Sandimmun) therapy: experience in the treatment of pars planitis and present therapeutic guidelines.

Authors:  R B Nussenblatt; A G Palestine
Journal:  Dev Ophthalmol       Date:  1992

Review 4.  Corticosteroids in the treatment of intermediate uveitis.

Authors:  D J Forster; N A Rao; R E Smith
Journal:  Dev Ophthalmol       Date:  1992

5.  Intermediate uveitis: history, terminology, definition pars planitis: systemic disease associations.

Authors:  W J Dinning
Journal:  Dev Ophthalmol       Date:  1992

6.  Cellular phenotype of vitreous cells in intermediate uveitis.

Authors:  B Nölle; C Eckardt
Journal:  Dev Ophthalmol       Date:  1992

7.  Clinical and immunopathological studies of pars planitis in a family.

Authors:  R P Wetzig; C C Chan; R B Nussenblatt; A G Palestine; D O Mazur; K K Mittal
Journal:  Br J Ophthalmol       Date:  1988-01       Impact factor: 4.638

8.  Changing patterns of uveitis.

Authors:  D E Henderly; A J Genstler; R E Smith; N A Rao
Journal:  Am J Ophthalmol       Date:  1987-02-15       Impact factor: 5.258

9.  Fluorescein angiography of peripheral uveitis.

Authors:  R C Pruett; J Brockhurst; N F Letts
Journal:  Am J Ophthalmol       Date:  1974-04       Impact factor: 5.258

10.  The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis.

Authors:  S M Malinowski; J S Pulido; N E Goeken; C K Brown; J C Folk
Journal:  Ophthalmology       Date:  1993-08       Impact factor: 12.079

View more
  3 in total

1.  Clinical characteristics of intermediate uveitis in Tunisian patients.

Authors:  Moncef Khairallah; Kamel Hmidi; Sonia Attia; Bechir Jelliti; Wafa Hasnaoui; Sonia Zaouali; Salah Jenzeri; Salim Ben Yahia; Riadh Messaoud
Journal:  Int Ophthalmol       Date:  2010-03-05       Impact factor: 2.031

2.  Intermediate uveitis in Indian population.

Authors:  Swapnil Parchand; Manjari Tandan; Vishali Gupta; Amod Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-02-23

3.  Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials.

Authors:  Hammad A Qazi
Journal:  J Res Med Sci       Date:  2012-12       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.